Tazorac Related Published Studies
Well-designed clinical trials related to Tazorac (Tazarotene Cutaneous)
Randomized comparison of the safety and efficacy of tazarotene 0.1% cream and adapalene 0.3% gel in the treatment of patients with at least moderate facial acne vulgaris. [2010.05]
Comparative efficacy and safety results of two topical combination acne regimens. [2009.07]
Randomized double-blind trial of prophylactic oral minocycline and topical tazarotene for cetuximab-associated acne-like eruption. [2007.12.01]
Tolerability comparison of adapalene gel, 0.3% versus tazarotene cream, 0.05% in subjects with healthy skin. [2007.06]
Comparison of clinical efficacy of topical tazarotene 0.1% cream with topical clobetasol propionate 0.05% cream in chronic plaque psoriasis: a double-blind, randomized, right-left comparison study. [2007.01]
Tazarotene versus tazarotene plus hydroquinone in the treatment of photodamaged facial skin: a multicenter, double-blind, randomized study. [2006.09]
[Inhibition of promyelocytic leukemia gene by tazarotene in hyperproliferative epidermis of psoriasis] [2006.08]
Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: a multicenter, double-blind, randomized, parallel-group study. [2006.05]
Tazarotene versus tazarotene plus clindamycin/benzoyl peroxide in the treatment of acne vulgaris: a multicenter, double-blind, randomized parallel-group trial. [2006.03]
Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin: a double-blind, randomized, vehicle-controlled study. [2006.01]
Tazarotene cream versus adapalene cream in the treatment of facial acne vulgaris: a multicenter, double-blind, randomized, parallel-group study. [2005.03]
A multicenter, randomized, double-blind trial of tazarotene 0.1% cream in the treatment of photodamage. [2005.02]
Comparison of tazarotene 0.1% gel plus petrolatum once daily versus calcipotriol 0.005% ointment twice daily in the treatment of plaque psoriasis. [2005]
Well-designed clinical trials possibly related to Tazorac (Tazarotene Cutaneous)
Adapalene 0.1% and benzoyl peroxide 2.5% as a fixed-dose combination gel is as well tolerated as the individual components alone in terms of cumulative irritancy. [2008.09]
Cumulative irritancy comparison of topical retinoid and antimicrobial combination therapies. [2006.09]
Other research related to Tazorac (Tazarotene Cutaneous)
Clindamycin phosphate 1.2%-benzoyl peroxide (5% or 2.5%) plus tazarotene cream
0.1% for the treatment of acne. [2013]
Cumulative irritation potential and contact sensitization potential of tazarotene
foam 0.1% in 2 phase 1 patch studies. [2012]
A randomized trial of the off-label use of imiquimod, 5%, cream with vs without
tazarotene, 0.1%, gel for the treatment of lentigo maligna, followed by
conservative staged excisions. [2012]
Clinical evidence for the role of a topical anti-inflammatory agent in comedonal acne: findings from a randomized study of dapsone gel 5% in combination with tazarotene cream 0.1% in patients with acne vulgaris. [2011.07]
Efficacy and safety study of tazarotene cream 0.1% for the treatment of brittle nail syndrome. [2011.02]
Evaluation of topical 0.1% tazarotene cream in the treatment of palmoplantar psoriasis: an observer-blinded randomized controlled study. [2011.01]
Clinical evidence for the role of a topical anti-inflammatory agent in comedonal
acne: findings from a randomized study of dapsone gel 5% in combination with
tazarotene cream 0.1% in patients with acne vulgaris. [2011]
Topical tazarotene cream (0.1%) in the treatment of facial acne: an open clinical trial. [2010.08]
Topical tazarotene vs. coal tar in stable plaque psoriasis. [2010.07]
Rapid improvement in digital ischemia and acral contracture in a collodion baby treated with topical tazarotene. [2010.06]
Randomized comparison of the safety and efficacy of tazarotene 0.1% cream and
adapalene 0.3% gel in the treatment of patients with at least moderate facial
acne vulgaris. [2010]
Mimicry illuminating pitfalls in histopathologic diagnosis: nutritional deficiency-like dermatitis secondary to topical tazarotene and keratoacanthomatous pseudocarcinomatous hyperplasia in CD30+ lymphoproliferative disorder as illustrative. [2009.02]
Efficacy and safety of topical tazarotene: a review. [2009.02]
Comparative study of calcipotriol (0.005%) ointment and tazarotene (0.05% and 0.1%) gel in the treatment of stable plaque psoriasis. [2008.09]
Adapalene 0.1% gel compared to tazarotene 0.1% cream in the treatment of acne vulgaris. [2008.06]
Efficacy and tolerability of adapalene 0.3% gel compared to tazarotene 0.1% gel in the treatment of acne vulgaris. [2008.06]
Response of juvenile circumscribed pityriasis rubra pilaris to topical tazarotene treatment. [2008.01]
A review of tazarotene in the treatment of photodamaged skin. [2008]
Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris. [2007.07.13]
Childhood nail psoriasis: a useful treatment with tazarotene 0.05%. [2007.05]
Erythrokeratoderma variabilis successfully treated with topical tazarotene. [2006.07]
Ichthyosis bullosa of Siemens: response to topical tazarotene. [2006.01]
Linear Darier's disease successfully treated with 0.1% tazarotene gel "short-contact" therapy. [2006.01]
Receptor-selective retinoids for psoriasis: focus on tazarotene. [2006]
Short contact therapy with tazarotene in psoriasis vulgaris. [2006]
Disposition and biotransformation of the acetylenic retinoid tazarotene in humans. [2005.10]
Cumulative irritation potential of adapalene 0.1% cream and gel compared with tazarotene cream 0.05% and 0.1%. [2005.05]
Tazarotene cream (0.1%) in combination with betamethasone valerate foam (0.12%) for plaque-type psoriasis. [2005.03]
Topical tazarotene: a review of its use in the treatment of plaque psoriasis. [2005]
Advances in therapy for psoriasis: an overview of infliximab, etanercept, efalizumab, alefacept, adalimumab, tazarotene, and pimecrolimus. [2005]
Other possibly related research studies
Clinical inquiries. What is the best treatment for mild to moderate acne? [2006.11]
Schools of pharmacology: retinoid update. [2006.10]
[From the Cochrane Library: Improvement of photodamaged skin with retinoid creams and not with other local treatments] [2006.01.21]
Comedolytic effect of a novel RARgamma-specific retinoid, ER36009: comparison with retinoic acid in the rhino mouse model. [2005.11]
Modern modified 'ultra' Goeckerman therapy: a PASI assessment of a very effective therapy for psoriasis resistant to both prebiologic and biologic therapies. [2005.04]
Corticosteroids: options in the era of steroid-sparing therapy. [2005.07]
Mechanisms of the comedolytic and anti-inflammatory properties of topical retinoids. [2005.01]
Interventions for photodamaged skin. [2005.01.25]
Confluent and reticulated papillomatosis : a review of the literature. [2006]
Management of refractory early-stage cutaneous T-cell lymphoma. [2006]
Open-label pilot study of alitretinoin gel 0.1% in the treatment of photoaging. [2005.07]
The role of topical retinoids in the treatment of photoaging. [2005]
Topical retinoids in inflammatory acne: a retrospective, investigator-blinded, vehicle-controlled, photographic assessment. [2005.02]
Pharmacological treatments for Basal cell carcinoma. [2007]
New lesions on the knees with palmoplantar keratoderma. [2007.01]
Treatment of childhood psoriasis. [2006]
Multiple keratoacanthomas in a young woman: report of a case emphasizing medical management and a review of the spectrum of multiple keratoacanthomas. [2007.01]
Palliative treatment of fingernail lichen planus. [2007.02]
Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy. [2007.07]
Treatment of locally metastatic melanoma: a novel approach. [2007.08]
Effects of topically applied acitretin in reconstructed human epidermis and the rhino mouse. [2008.01]
Treatment of lentigo maligna with imiquimod before staged excision. [2008.02]
[Topical corticosteroids and corticosteroid sparing therapy in psoriasis management] [2007.09]
A case report of Hailey-Hailey disease treated with alefacept (Amevive). [2008.02]
Is switching retinoids a sound strategy for the treatment of acne vulgaris? [2008.06]
Cosmeceuticals: focus on topical retinoids in photoaging. [2008.11]
Pharmacologic retinoid signaling and physiologic retinoic acid receptor signaling inhibit basal cell carcinoma tumorigenesis. [2008.05]
Hand foot skin reaction in cancer patients treated with the multikinase inhibitors sorafenib and sunitinib. [2008.11]
[Update of the topical treatment of psoriasis] [2009.04]
[Topical treatments for psoriasis in 2009] [2009.04.22]
Topical treatments for chronic plaque psoriasis. [2009.04.15]
Changing the face of acne therapy. [2009.02]
Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. [2009.04]
Psoriasis disappearance after the first phase of an oncologic treatment: a serendipity case report. [2008.11]
Topical retinoids in acne vulgaris: update on efficacy and safety. [2008]
Topical retinoids in acne--an evidence-based overview. [2008.12]
Topical treatments for chronic plaque psoriasis. [2010.03.01]
[Narrow-band UVB therapy in psoriasis vulgaris: good practice guideline and recommendations of the French Society of Photodermatology] [2010.01]
New and experimental skin-directed therapies for cutaneous lymphomas. [2009]
Practice of phototherapy in the treatment of moderate-to-severe psoriasis. [2009]
Effect of retinoid pretreatment on outcomes of patients treated by photodynamic therapy for actinic keratosis of the hand and forearm. [2011.10.01]
Evidence-based review: fixed-combination therapy and topical retinoids in the treatment of acne. [2011.06]
Use of topical tretinoin and the development of noncutaneous adverse events: Evidence from a systematic review of the literature. [2011.12]
Do lasers or topicals really work for nonmelanoma skin cancers? [2011.03]
Psoriasis in the elderly: from the Medical Board of the National Psoriasis Foundation. [2011.09]
Bullous-hemorrhagic Darier disease. [2011.01]
[Retinoids: mechanisms of action]. [2010.11]
Topical retinoids in the management of photodamaged skin: from theory to evidence-based practical approach. [2010.12]
Effect of retinoid pretreatment on outcomes of patients treated by photodynamic
therapy for actinic keratosis of the hand and forearm. [2011]
Topical treatments for chronic plaque psoriasis. [2013]
Interventions for nail psoriasis. [2013]
Interventions for melanoma in situ, including lentigo maligna. [2014]
|
